ATP2B4 and heart failure: However, we found a dramatic reduction in heart function and a higher mortality rate in WT mice compared with PMCA4−/− mice after 12 weeks of TAC, indicating that PMCA4 ablation may preserve cardiac contractile function and protect against the development of heart failure in the chronic pressure overload model.